Clinical Trials Directory

Trials / Sponsors / Life Molecular Imaging SA

Life Molecular Imaging SA

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
TerminatedImaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain
Mild Traumatic Brain Injury
Phase 12021-06-07
TerminatedPET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate C
Prostate Cancer
Phase 1 / Phase 22015-05-01
TerminatedPET Imaging of Intracranial Cancers With 18F-FSPG
Brain Cancer
Phase 12014-11-01
CompletedPET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Fol
Diagnostic Imaging
Phase 12011-05-01
CompletedPET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic P
Diagnostic Imaging
Phase 12011-02-01
CompletedExploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer
Neoplasms
Phase 12010-12-01
CompletedPET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and
Diagnostic Imaging
Phase 12010-11-01
CompletedEvaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Vo
Diagnostic Imaging
Phase 12010-06-01
CompletedPET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers
Diagnostic Imaging
Phase 12010-05-01
CompletedRadiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in
Diagnostic Imaging, Neoplasms
Phase 12010-04-01
CompletedPhase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared
Alzheimer Disease
Phase 32009-11-01
CompletedPhase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
Down Syndrome, Amyloid Beta-protein
Phase 22009-06-01
CompletedPhase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patie
Alzheimer Disease, Amyloid Beta-Protein
Phase 22008-08-01
CompletedFlorbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patient
Alzheimer Disease, Amyloid Beta-Protein
Phase 12008-06-01